Study of Tamsulosin Hydrochloride Sustained- Release Capsules Based on QbD Theory

Yun HUANG,Jun XIE,Jun YANG,Wei-guo TANG,Jian-ping ZHOU

DOI: https://doi.org/10.13664/j.cnki.pcr.2018.01.004

2018-01-01

Abstract:Tamsulosin hydrochloride was used as the model drug to apply the quality by design theory in preparing sustained-release pellets. The drug-containing cores were prepared by extrusion-spheronization, and then the cores were coated with a fluidized bed to form the enteric-coated sustained-release pellets. After the reference was deeply analyzed, the critical quality attributes were determined as the drug release in pH 1.2 for 2 h and the accumulative release after the pallets were transferred to pH 7.2 buffer for 1 h and 3 h. According to the risk assessment, the most significant risk factors were determined as the percentage of Eurdragit?NE30D in the core (X1), the percentage of Eudragit?L30D-55 in the coating membranes (X2) and the coating weight gain (X3). The central composite design-response surface method was chosen to describe the relationship between the high risk factors and the critical quality attributes. From the response surface, the design space of the risk factors was confirmed as: X1at 18.8%-21.0%, X2 at 15.0%-20.2% and X3at 4.3%-6.1%. With the above space, the quality-controlled products that meet the expectation were got.